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remained significantly associated with risk of PE (RR 3.9, 
p = 0.02), when adjusting for comorbidities. BMI > 35 
was associated with highest risk of PE (RR 5.7, p = 0.003). 
The risk of periprosthetic femoral fracture was 0.2% after 
cemented/hybrid vs. 1.5% after cementless THA (p < 0.001) 
and the risk of dislocations was 1.2% after cemented/hybrid 
THA vs. 1.8% after cementless THA (p = 0.04).
Interpretation — The higher risk of PE after cemented/
hybrid THA and higher risk of periprosthetic femoral frac-
tures and dislocations after cementless THA highlights that 
both medically and surgically complications are related to 
fixation technique and have to be considered.
The use of a cementless fixation technique in total hip 
arthroplasties (THA) is generally preferred compared with a 
cemented technique in patients with hip osteoarthrosis and age 
< 70 years in most Western countries. The use of cementless 
implants in THA has increased in all age groups including the 
elderly (AOANJRR 2018, DHR 2018, NJR 2018) despite the 
fact that cementless femoral components are associated with 
increased risk of early periprosthetic femoral fractures, espe-
cially in patients > 70 years (Makela et al. 2014, Thien et al. 
2014, Lindberg-Larsen et al. 2017, Tanzer et al. 2018).
Background and purpose — The use of cementless total 
hip arthroplasty (THA) in elderly patients is debated because 
of increased risk of early periprosthetic femoral fractures. 
However, cemented femoral components carry a risk of bone 
cement implantation syndrome. Hence, we compared in-hos-
pital complications, complications leading to readmission 
and mortality ≤ 30 days postoperatively between hybrid/
cemented (cemented femoral component) vs. cementless 
THA in osteoarthritis patients > 70 years.
Patients and methods — This is a prospective observa-
tional cohort study in 9 centers from January 2010 to August 
2017. We used 30-day follow-up from the Danish National 
Patient Registry, patient records, and data from the Danish 
Hip Arthroplasty Register. Only THAs performed as a result 
of osteoarthritis were included.
Results — 3,368 (42%) of the THAs were cemented/
hybrid and 4,728 (58%) cementless. The in-hospital com-
plication risk was 7.7% after cemented/hybrid vs. 5.3% after 
cementless THA (< 0.001), statistically not significant when 
adjusting for comorbidities (p = 0.1). There were similar 
risks of complications causing readmission (5.7% vs. 6.2%) 
and mortality ≤ 30 days (0.2% vs. 0.3%). 15 cases (0.4%) 
of pulmonary embolism (PE) were found after cemented/
hybrid vs. 4 (0.1%) after cementless THA (p = 0.001); none 
occurred within 24 hours postoperatively. 2 of the PEs after 
cementless THA led to mortality. Cemented/hybrid THA 
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A concern regarding the use of cemented femoral compo-
nents is the risk of the so-called bone cement implantation syn-
drome. The syndrome occurs at the time of bone cementation 
and prosthesis insertion where the high intra-medullary pres-
sure forces medullary fat emboli into the circulation resulting 
in risk of pulmonary embolism (Orsini et al. 1987, Donaldson 
et al. 2009, Segerstad et al. 2019). The clinical presentation 
of this syndrome may range from hypoxia to fulminatory pul-
monary and systemic marrow embolization, right ventricular 
failure, and circulatory collapse (Issack et al. 2009). The inci-
dence has been difficult to determine due to the variation of 
severity of the syndrome. In a series of 1,016 cemented hemi-
arthroplasty patients, the incidence of the most severe grade of 
the syndrome (grade 3) was 1.7% and associated with mortal-
ity of 88%. Risk factors for the syndrome were ASA grade 
III–IV, chronic obstructive pulmonary disease, and medication 
with diuretics or warfarin (Olsen et al. 2014). However, the 
exact incidence and consequences of bone cement implanta-
tion syndrome after total hip arthroplasty remains unknown. 
As occurrence of severe bone cement implantation syndrome 
would likely influence postoperative length of hospital stay, 
readmission risk, or mortality, we compared in-hospital com-
plications, complications leading to readmission, and mortal-
ity within 30 days postoperatively between hybrid/cemented 
(cemented femoral component) versus cementless THA in 
osteoarthritis patients > 70 years.
Patients and methods 
This is a prospective observational cohort study on patients 
from the Lundbeck Foundation Centre for Fast-track THA 
and TKA database (LCDB 2019). The STROBE guidelines 
for reporting observational studies were followed. Data on 
9,037 primary unselected elective THA procedures performed 
in patients > 70 years were prospectively collected between 
February 2010 and August 2017 in 9 departments reporting to 
the LCDB. Supplementary data on fixation technique, dura-
tion of surgery, indication, and previous surgeries were avail-
able from the Danish Hip Arthroplasty Registry (DHR 2018) 
in 98% of cases. Hence, 8,096 primary elective THA proce-
dures performed in patients with primary osteoarthritis were 
available for analysis after exclusions (Figure 1). The indica-
tion for either cemented/hybrid or cementless THA was based 
on surgeon and center preference and varied between centers. 
The percentage of cemented/hybrid THA ranged from 4% to 
95% with great interdepartmental variation. 
The procedures were divided into cemented/hybrid 
(cemented femoral components) versus cementless THA 
(cementless femoral and acetabular components). Reverse 
hybrid THA procedures (cementless femoral component and 
cemented acetabular component) were excluded. Patients reg-
istered in the DHR as operated on for indications other than 
osteoarthritis were excluded. Furthermore, patients having 
simultaneous bilateral procedures or an additional major 
arthroplasty procedure within 90 days were excluded (Figure 
1).
The Lundbeck Foundation Centre for Fast-track THA 
and TKA Database (LCDB)
The LCDB is a prospective database on unselected consecu-
tive primary hip and knee arthroplasty procedures from 9 con-
tributing centers initiated in January 2010 in 6 Danish centers, 
and an additional 3 centers joined the collaboration in 2012, 
2013, and 2014 (LCDB 2019). The LCDB contains data on 
preoperative comorbidity and patient characteristics such as 
pharmacologically treated cardiopulmonary disease, diabetes, 
previous venous thromboembolism (VTE), alcohol consump-
tion, smoking habits, and living conditions (Table 1). Data are 
prospectively collected from patients within 1 month before 
surgery using self-completed questionnaires with staff avail-
able for assistance. Validation of the consistency of the preop-
erative patient questionnaire has been performed previously 
using matched patient medical records (Pitter et al. 2016). 
The study period for the current updated detailed analysis 
was from January 2010 until August 2017. All collaborating 
centers adhered to similar fast-track protocols, including use 
of spinal anesthesia (≈90%), multi-modal opioid-sparing anal-
gesia, early mobilization, and discharge to own home based 
on functional discharge criteria. Thromboprophylaxis was 
prescribed according to local guidelines including thrombo-
prophylaxis administered 6–8 hours after surgery, consist-
ing of either rivaroxaban (Xarelto, Bayer Pharma, Berlin, 
Germany) 10 mg/day, enoxaparin (Klexane, Sanofi-Aventis, 
Paris, France) 4,000 IU/day, dalteparin (Fragmin, Pfizer 
Health Care, New York, USA) 5,000 IU/day, or fondaparinux 
(Arixtra, GlaxoSmithKline, London, UK) 2.5 mg/day. Throm-
boprophylaxis was used only during hospitalization if LOS 
was ≤ 5 day. If LOS > 5 days recommendations on duration 
varied in the study period. From 2010 to 2016 international 
guidelines with thromboprophylaxis for up to 35 days for 
Figure 1. Flow-chart inclusion. 
DNPR: Danish National Patient Register; LCDB: Lundbeck Founda-
tion Centre for Fast-track THA and TKA Database; DHR: Danish Hip 
Arthroplasty Register. 
a Including fracture, rheumatoid arthritis, tumor cases, and sequelae 
after fracture. 
b Cemented acetabular component and cementless femoral component.
Primary THA in patients
> 70 years registered
in DNPR and LCDB
n = 9,037
Analyzed THAs (n = 8,096):
– cementless, 4,728
– cemented/hybrid, 3,368
Excluded (n = 941):
– no DHR data, 168
– indication not osteoarthritis a, 722
– no data on fixation technique, 17
– reverse hybrid THA b, 34
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THA were recommended and from 2016 the Danish recom-
mendation changed to 6–10 days (RADS 2016). Compression 
stockings or intermittent pneumatic compression devices were 
not used. Pulsatile lavage was used as a standard procedure in 
cemented THA surgery in the participating centers. 
Outcomes
Complications within 30 days postoperatively leading to 
length of hospital stay (LOS) > 4 days, readmission, and 
mortality were analyzed. All patients with a LOS of > 4 days 
had their medical records examined to determine the reason 
for prolonged LOS and in-hospital complications during pri-
mary admission. Using the patients’ unique Danish social 
security numbers, we obtained information on LOS, 30-day 
readmissions, and mortality from the Danish National Patient 
Registry. As reporting to the Danish National Patient Regis-
try is mandatory for hospitals to receive reimbursement, an 
almost complete follow-up (> 99%) is assured (Schmidt et al. 
2015). All unplanned readmissions with an overnight hospital 
stay within 30 days postoperatively were evaluated to deter-
mine postoperative complications after discharge. Discharge 
records or patient records of readmitted patients were scruti-
nized and relation to index surgery was evaluated. Causes of 
mortality within 30 days were evaluated using patient records.
In the case of pulmonary embolism (PE) in the discharge 
summary the entire medical record was evaluated to confirm 
the occurrence of PE and identify any possible causative 
events. The PE diagnosis was in all cases confirmed by spiral 
computed tomography (CT). 
Statistics
Overall comparative analysis of the groups was performed 
using Student’s t-test for normally distributed data and crude 
comparisons of proportions were done using a chi-square test. 
Analysis of potential risk factors associated with in-hospital 
complications and PE was performed using a multivariable 
Poisson regression model with robust error variance (Zou 
2004). Cases with missing data were excluded from analysis. 
A sensitivity analysis on risk of PE, periprosthetic fractures, 
and dislocations after excluding 165 (85+80) cemented/hybrid 
THA from 2 centers performing < 10% cemented/hybrid THA 
and 14 cementless THA from 1 center performing < 10% 
cementless THA was performed.
Results are given as relative risk (RR) estimates or per-
centages with 95% confidence intervals (CI). Any p-value of 
< 0.05 was considered significant. Analysis was done using 
SPSS version 22 (IBM Corp, Armonk, NY, USA).
Ethics, registration, funding, and potential conflicts of 
interests
According to Danish law no approval from the regional ethics 
committee was required as the study was non-interventional. 
Permission to obtain and store data without informed con-
sent was obtained from the Danish Patient Safety Authority 
(3-3013-56/2/EMJO) and the Danish Data Protection Agency 
(RH-2014-132). The LCDB is registered as an ongoing study 
registry on clinicaltrials.gov (NCT01515670). This study was 
funded by the Lundbeck Foundation Centre for Fast-Track 
Hip and Knee Arthroplasty, Copenhagen, Denmark. No com-
peting interests were declared.
Results 
8,096 primary elective THA procedures performed in 7,786 
osteoarthritis patients > 70 years were analyzed (Figure 1). 
In 42% of the procedures a cemented or hybrid (cemented 
femoral component) fixation technique was used and 58% 
Table 1. Patient characteristics. Values are number (%) unless oth-
erwise specified
 Cemented/
 hybrid THA a Cementless THA
Patient characteristics n = 3,368 (42%) n = 4,728 (58%)
Mean age (range)  79 (71–100) 76 (71–97)
Female sex 2,311 (69) 2,641 (56)
Mean BMI (range) 26 (14–64) 26 (15–61)
 missing 24 (0.7) 29 (0.6)
Use of walking aid 1,374 (41) 1,421 (30)
 missing 78 (2.3) 98 (2.1)
Smoking 341 (10) 448 (9.5)
 missing 23 (0.7) 27 (0.6)
Alcohol > 2 units/day  114 (3.4) 375 (7.9)
 missing 36 (1.1) 26 (0.5)
Type 1 diabetes 25 (0.7) 24 (0.5)
 missing 22 (0.7) 25 (0.5)
Type 2 diabetes 319 (9.5) 463 (9.8)
 missing 20 (0.6) 11 (0.2)
Pharmacologically treated 
  cardiovascular disease 664 (20) 831 (18)
 missing 42 (1.2) 40 (0.8)
Pharmacologically treated 
  pulmonary disease 362 (11) 421 (8.9)
 missing 24 (0.7) 26 (0.5)
Prior cerebral stroke 219 (6.5) 350 (7.4)
 missing 65 (1.9) 60 (1.3)
History of VTE 261 (7.7) 367 (7.8)
 missing 95 (2.8) 60 (1.3)
Hereditary VTE 362 (11) 470 (9.9)
 missing 347 (10) 623 (13)
Hypercholesterolemia  1,422 (42) 1,780 (38)
 missing 25 (0.7) 24 (0.5)
Anticoagulative treatment 689 (21) 850 (18)
 missing 32 (1.0) 49 (1.0)
Preoperative anemia b 1,193 (35) 1,313 (28)
 missing 23 (0.7) 34 (0.7)
Hypertension 1,994 (59) 2,689 (57)
 missing 11 (0.3) 20 (0.4)
Pharmacologically treated 
  psychiatric disorder 259 (7.7) 303 (6.4)
 missing 28 (0.8) 23 (0.5)
a Hybrid = cemented femoral component
b Hb < 13 g/dL.
THA: total hip arthroplasty
VTE: venous thromboembolism  
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were performed using a cementless technique. There were 
more females in the cemented/hybrid group (69%) compared 
with the cementless group (56%), but otherwise demographics 
were similar between groups (Table 1). 
The in-hospital complication rate was 7.7% after cemented/
hybrid THA vs. 5.3% after cementless THA (< 0.001) (Table 
2), but statistically not significant (RR 1.1, p = 0.2) when 
adjusting for preoperative comorbidity (Table 3). The most 
frequent in-hospital complication causing prolonged LOS > 4 
days was pain and mobilization problems after both cemented/
hybrid and cementless THA (1.5%, n = 50 and 1.1%, n = 50 
respectively). All in-hospital complications are presented in 
Figure 2. 
The 30-day overall readmission risk was 6.5% after 
cemented/hybrid vs. 7.0% after cementless THA. When sub-
tracting readmissions due to suspected but disproven VTE/
infections the readmission risk was 5.7% after cemented/
hybrid vs. 6.2% after cementless THA (p = 0.4). The most 
frequent complications causing readmission were hip disloca-
tions (0.8%, n = 27), periprosthetic joint infection (0.7%, n = 
24), and cardiac complications (0.7%, n = 22) after cemented/
hybrid THA whereas hip dislocations (1.6%, n = 78) and peri-
prosthetic femoral fractures (1.0%, n = 46) were most frequent 
after cementless THA (Figure 3). 
7 cases of PE during primary admission and 8 PEs leading 
to readmission ≤ 30 days were found after cemented/hybrid 
THA compared with 2 cases of PE during primary admis-
sion and 2 PE leading to readmission after cementless THA. 
Pulmonary embolism (PE) and time course from surgery as 
well as information on thromboprophylaxis at time of PE are 
presented in Table 4. 2 of the PEs after cementless THA led 
to mortality. Hence, 15 cases (0.4%) of PE were found after 
cemented/hybrid vs. 4 (0.1%) after cementless THA within 30 
days postoperatively (p = 0.001). None of the PEs occurred 
within 24 hours postoperatively. Cemented/hybrid THA 
remained significantly associated (RR 3.9, p = 0.022) with 
risk of PE in the regression model (Table 5). 
2 cases of periprosthetic femoral fractures during primary 
admission and 5 leading to readmission ≤ 30 days were found 
after cemented/hybrid THA compared with 24 periprosthetic 
femoral fractures during primary admission and 46 leading to 
readmission after cementless THA (Figures 2–3). Hence, 7 
cases (0.2%) of periprosthetic femoral fractures were found 
after cemented/hybrid vs. 70 (1.5%) after cementless THA 
within 30 days postoperatively (p < 0.001). In 1 of 7 cases of 
periprosthetic fractures after cemented/hybrid THA revision 
surgery was needed and the remaining 6 cases were treated 
nonoperatively. In contrast, 39 of 70 cases of periprosthetic 
fracture after cementless THA needed revision surgery and the 
Table 2. Postoperative 30-day outcome. Values are count (%)
 Cemented/ Cementless
 hybrid THA THA p-value
Outcomes n = 3,368 n = 4,728
Mortality 8 (0.2) 15 (0.3) 0.5
In-hospital complications 260 (7.7) 252 (5.3) < 0.001
Complications causing 
 readmission 193 (5.7) 292 (6.2) 0.4
Pulmonary embolism 15 (0.4) 4 (0.1) 0.001
Periprosthetic femoral fractures 7 (0.2) 70 (1.5) < 0.001
Dislocations 42 (1.2) 87 (1.8) 0.04
Table 3. Multivariable Poisson regression analysis of potential risk 
factors influencing the risk of in-hospital complications
Potential risk factor RR (95 % CI)
Cemented/hybrid THA 1.1 (0.9–1.3)
Pharmacologically treated cardiovascular disease 1.5 (1.2–1.8)
Pharmacologically treated pulmonary disease 1.4 (1.1–1.8)
History of venous thromboembolism 1.6 (1.2–2.0)
BMI ≥ 35 2.1 (1.5–2.9)
Use of mobility aid 2.1 (1.8–2.6)
Age (per 10 years) 2.1 (1.8–2.5)
RR: Relative risk; BMI: body mass index.
Figure 3. Complications causing readmission ≤ 30 days postopera-
tively.
Figure 2. In-hospital complications causing LOS > 4 days.
Cardiac
Pulmonary
Venous thromboembolism
Cerebral
Renal/fluid related
Urological
Gastrointestinal
Anemia
Other medical complications
Pain/mobilization problems
Hip dislocation
Periprosthetic fracture
Oozing/hematoma
Periprosthetic infection
Other surgical complications
0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0
Cementless
Cemented/hybrid
Complications (%)
Cardiac
Pulmonary
Venous thromboembolism
Cerebral
Renal/fluid related
Urological
Gastrointestinal
Anemia
Other medical complications
Pain/mobilization problems
Fall related
Susp. DVT/infection, not found
Hip dislocation
Periprosthetic fracture
Oozing/hematoma
Periprosthetic infection
Other surgical complications
0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0
Cementless
Cemented/hybrid
Complications (%)
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remainder were treated nonoperatively (25 cases) or treated at 
primary surgery with wiring/osteosynthesis (6 cases). 
The risk of dislocations was 1.2% (15 during primary 
admission and 27 causing readmission) after cemented/hybrid 
THA vs. 1.8% (9 during primary admission and 78 causing 
readmission) after cementless THA (p = 0.04). 
A sub-analysis on risk of dislocations comparing groups 
based on acetabular fixation was performed and the risk of 
dislocations was similar: 1.6% (5 during primary admission 
and 3 causing readmission) after the use of cemented vs. 1.6% 
(19 during primary admission and 102 causing readmission) 
after cementless acetabular components.  
The postoperative mortality ≤ 30 days was 0.2% after 
cemented/hybrid vs. 0.3% after cementless THA (p = 0.5). 
Time course and causes of 30-day mortality are presented in 
Table 6.
Table 4. Pulmonary embolism (PE) and time course from surgery
 Days from Place of Ongoing  Preoperative
 surgery PE thrombo- Previous anticoagulant  PE-related
 to PE diagnosis prophylaxis VTE therapy a Age mortality
Cemented/hybrid (n = 15) 
 2 Primary admission Yes Yes  85 
 2 Primary admission Yes   75 
 2 Primary admission Yes  Yes 86 
 2 Primary admission Yes   81 
 3 Readmission No   77 
 3 Primary admission Yes   78 
 4 Primary admission Yes Yes  82 
 7 Readmission No   84 
 8 Readmission No   92 
 10 Readmission No   73 
 13 Readmission No   71 
 14 Readmission No   87 
 23 Primary admission Yes Yes  79 
 26 Readmission Yes  Yes 84 
 27 Readmission No   84 
Cementless (n = 4) 
 1 Primary admission Yes   73 
 2 Readmission Yes  Yes 78 Yes
 14 Primary admission Yes   71 Yes
 17 Readmission No   89 
a All 3 patients treated with warfarin pre- and postoperatively. 
VTE: venous thromboembolism.
A sensitivity analysis on risk of PE, peri-
prosthetic fractures, and dislocations after 
excluding 165 (85+80) cemented/hybrid THA 
from 2 centers performing < 10% cemented/
hybrid THA and 14 cementless THA from 1 
center performing < 10% cementless THA 
revealed no differences from the risk esti-
mates presented above. 
Discussion
The use of cementless THA implants in 
patients > 70 years is debatable due to the 
increased risk of early periprosthetic frac-
tures (Makela et al. 2014, Lindberg-Larsen 
et al. 2017, Tanzer et al. 2018). One of the 
arguments for the use of cementless implants 
may be the risk of bone cement implantation 
syndrome (Olsen et al. 2014) and the poten-
tially associated mortality after cementation 
(McMinn et al. 2012, Garland et al. 2017). 
However, the actual impact of the use of 
cement on the overall risk of postoperative 
Table 5. Multivariable Poisson regression analysis of potential risk 
factors influencing the risk of pulmonary embolism (PE)
Potential risk factor RR (95% CI)
Cemented and hybrid THA 3.9 (1.2–13)
Pharmacologically treated cardiovascular disease 1.9 (0.7–5.3)
Pharmacologically treated pulmonary disease 1.0 (0.2–4.8)
History of venous thromboembolism 2.0 (0.6–6.6)
BMI ≥ 35 5.7 (1.6–20)
Use of mobility aid 1.6 (0.6–4.4)
Age (per 10 years) 1.6 (0.6–4.2)
Table 6. Mortality, time course from surgery and cause of death 
 Days from
 surgery to Place
 death of death Age Cause
Cemented/hybrid THA (n = 8) 
 2 Primary admission 86 Ileus
 3 Primary admission 76 Respiratory insufficiency
 4 Home 100 Cardiac arrest (unknown)
 8 Primary admission 79 Stroke
 13 Readmission 77 Myocardial infarction
 22 Readmission 90 Renal insufficiency
 25 Primary admission 79 Stroke
 29 Readmission 88 Endocarditis
Cementless THA (n = 15) 
 2 Readmission 78 Pulmonary embolism
 2 Readmission 71 Cardiac arrest
 3 Primary admission 78 COPD, sepsis, ARI
 5 Readmission 82 UTI, sepsis
 5 Home 82 Cardiac arrest (arrhythmia)
 6 Primary admission 79 Pneumonia
 8 Primary admission 87 Stroke
 13 Readmission 88 Stroke
 13 Home 74 Unknown
 14 Readmission 71 Pulmonary embolism
 14 Primary admission 87 Pneumonia
 14 Primary admission 86 Myocardial infarctionI
 18 Readmission 71 Unknown
 23 Readmission 90 Pneumonia
 23 Readmission 94 Pneumonia
COPD: chronic obstructive pulmonary disease; 
ARI: acute renal insufficiency; 
UTI: urinary tract infection
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complications has not been described in detail previously. In 
this study, we report a higher risk of in-hospital complications 
after cemented/hybrid THA (cemented femoral component) 
compared with cementless THA (7.7% vs. 5.3%); however, 
this was unrelated to fixation technique when adjusting for pre-
operative patient comorbidities. Furthermore, an increased risk 
of 30-days postoperative PE after cemented/hybrid compared 
with cementless THA was found, and also when adjusting for 
comorbidities. The higher risk of PE can hardly be directly 
explained by cementation as none happened on the day of sur-
gery or the first day after and it seems unlikely that a potential 
low-grade bone cement implantation syndrome during surgery 
can affect the cardiopulmonary system, making the patient 
more at risk of PE later. The lack of a direct and timely rela-
tionship between cement implantation and the occurrence of 
postoperative PE suggests that other factors, such as obesity 
and delayed mobilization, may also contribute (Table 4). Fur-
thermore, many of the PE events happened despite ongoing 
thromboprophylaxis, indicating that these events happen in 
high-risk patients, requiring further investigations as discussed 
in detail by Petersen et al. (2019). We therefore feel that the 
term “bone cement implantation syndrome” should be used 
with more caution in this context. 
Whether the patients suffering PE in our study had detect-
able bone cement implantation syndrome intraoperatively 
cannot be confirmed in this study. Hence, our finding of clini-
cally documented postoperative PE of 0.4% after cemented/
hybrid THA is significantly higher than after cementless THA, 
but still much lower compared with the paraclinically reported 
incidence (28% [all grades]) of bone cement implantation syn-
drome (Olsen et al. 2014). 
Postoperative mortality in relation to the use of a cemented 
fixation technique in THA has been analyzed on a larger scale 
using data from the Swedish Hip Arthroplasty Register (n = 
178,784), finding a minimally increased relative risk of early 
mortality < 15 days postoperatively after cemented/hybrid 
THA compared with a matched control group from the general 
population, but the relative risk of mortality reversed > 15 days 
postoperatively (Garland et al. 2017). We found similar mortal-
ity rates between groups, but a larger cohort is needed to detect 
potentially statistically significant differences in mortality.
The higher risk of periprosthetic fractures after cementless 
THA, especially in the elderly (Makela et al. 2014, Thien et 
al. 2014, Lindberg-Larsen et al. 2017), is confirmed in our 
study, amounting to 1.5% after cementless THA compared 
with 0.2% after cemented/hybrid THA. Periprosthetic frac-
tures may cause protracted mobilization with limited weight-
bearing and when revision surgery is needed the procedures 
are complex and often associated with a high risk of complica-
tions and mortality (Bhattacharyya et al. 2007, Griffiths et al. 
2013). Our study includes only 30 days’ follow-up and hence 
more periprosthetic fractures, especially after cementless 
THA, with associated patient morbidity may be recognized 
later (Lindberg-Larsen et al. 2017). 
The higher risk of postoperative dislocations after cement-
less THA compared with a cemented/hybrid technique is in 
line with the higher revision rates due to dislocations reported 
in the Danish Hip Arthroplasty Register over the past decades 
after a cementless fixation technique for the femoral and ace-
tabular components (DHR 2018). A higher risk of dislocations 
after cementless THA has previously been explained by more 
variation in the positioning of the cementless acetabular com-
ponent (Chawda et al. 2009). However, we found that the risk 
of dislocation was similar (1.6%) when comparing cementless 
versus cemented acetabular components in our cohort in con-
trast to previous findings, supporting that the risk of disloca-
tion is multifactorial. 
The high proportion of cementless THA procedures (58%) 
performed in our population > 70 years is surprising, but in 
line with 53% cementless THAs performed in Denmark in 
2017 overall in the same age group (DHR 2018). This finding 
confirms the overall Danish trend of using cementless THA in 
all age groups. 
A limitation of this study is confounding by indication as no 
similar indication criteria for the use of a cemented fixation 
technique existed between centers. We tried to limit this by 
performing a sensitivity analysis on risk of PE, periprosthetic 
fractures, and dislocations after excluding cemented/hybrid 
THA from 2 centers performing < 10% cemented/hybrid 
THA and cementless THA from 1 center performing < 10% 
cementless THA. However, the results from the sensitivity 
analysis did not differ from the main analysis.
Although the registered preoperative patient comorbidity 
was similar, other confounding factors such functional status 
and bone quality (Dorr type) (Nash and Harris 2014) might 
have influenced surgeons’ choice. The type of cementless 
femoral component used may also have influenced the risk 
of periprosthetic fractures (Gromov et al. 2017) and this was 
not analyzed in the present study. Furthermore, the few PE 
events might lead to overfitting of the multivariable Poisson 
risk-factor analysis, potentially introducing a “type II error.” 
Another limitation of the study is the observational nature that 
excludes the possibility to report on causality. However, our 
study provides detailed information on complications lead-
ing to prolonged LOS or readmissions after cemented/hybrid 
THA versus cementless THA, which is necessary for shared 
decision-making between surgeons and patients.
A strength of this study includes prospective recording of 
numerous baseline characteristics, thus minimizing recall bias, 
an unselected consecutive patient population, and follow-up 
through a high-quality nationwide register, thereby ensuring 
data completeness (Schmidt et al. 2015). Other strengths are 
the standardized multicenter fast-track setup, and the rela-
tively short and recent study period. Furthermore, not relying 
on only diagnostic codes but using review of discharge notes 
and patient records for specific causes of morbidity ensures > 
99% follow-up for somatic readmissions (Schmidt et al. 2015) 
and eliminates the dependency on the questionable reliability 
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of a discharge diagnosis within the DNPR (Severinsen et al. 
2010, Sundboll et al. 2016, Bedard et al. 2018).
In conclusion, we report a higher risk of PE after cemented/
hybrid THA, but the risk of periprosthetic femoral fractures 
and dislocations was higher after cementless THA. These 
findings highlight that, both medically and surgically, compli-
cations are related to fixation technique and have to be consid-
ered in the decision-making on an individual level.
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